3P BIOTECH NORWAY AS: årsregnskap 2022 vs 2021
Grew 1428% on revenue, stronger earnings, cash halved-plus
approved 2023-06-30; registry 2023-08-09; journal 2023 704292
Summary
What changed
Comparing Årsregnskap 2022 with 2021 for 3P BIOTECH NORWAY AS. Revenue 73.4k NOK → 1.12m NOK (+1428.4%). Net result -53.6k NOK → -35.4k NOK. Equity 343.3k NOK → 307.9k NOK.
On the constructive side: revenue rose; net result improved. Pressures included: operating result weakened; equity eroded; cash fell.
Also worth watching: cogs moved. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 73.4k NOK to 1.12m NOK (+1428.4% YoY). Calculated
-
↑
Net result improved
Net result -53.6k NOK → -35.4k NOK (net margin -73.0% → -3.2%). Calculated
What deteriorated
-
↓
Operating result weakened
Operating result -6 253 NOK → -24.3k NOK (op. margin -8.5% → -2.2%). Calculated
-
↓
Equity eroded
Book equity 343.3k NOK → 307.9k NOK. Calculated
-
↓
Cash fell
Bank deposits 34.9k NOK → 129 NOK (-99.6% YoY). Calculated
Things to notice
-
·
COGS moved
COGS / varekostnad 10.9k NOK → 111.8k NOK (+927.9% YoY). Calculated